# Eagle Financial Services Inc: financial statements, quarterly

EFSI · Nasdaq · CIK 880641 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/efsi.md) · [Financials](/companies/efsi/financials.md) · [Filings](/companies/efsi/filings.md) · [Insiders](/companies/efsi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/efsi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [9,275](/filings/0000950170-23-063018.md) | [9,726 d](/filings/0000950170-24-038718.md) | [9,488](/filings/0000950170-25-008893.md) | [9,582](/filings/0000950170-25-008894.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [457](/filings/0000950170-25-008896.md) | [(99.0) d](/filings/0000950170-25-047778.md) | [495](/filings/0000950170-25-071376.md) | [585](/filings/0000950170-25-107957.md) | [550](/filings/0001193125-25-279991.md) | [1,928 d](/filings/0000880641-26-000004.md) | [(2,066)](/filings/0000880641-26-000013.md) | [1,278](/filings/0000880641-26-000023.md) | [1,324](/filings/0001193125-25-279991.md) | [1,175 d](/filings/0000880641-26-000004.md) | [918](/filings/0000880641-26-000013.md) | [1,545](/filings/0000880641-26-000023.md) |
| Net income | $k | [2,319](/filings/0000950170-25-047778.md) | [2,395](/filings/0000950170-25-047778.md) | [2,548](/filings/0000880641-26-000004.md) | [3,185](/filings/0000880641-26-000004.md) | [3,424](/filings/0000880641-26-000004.md) | [6,186](/filings/0000880641-26-000004.md) | [(6,974)](/filings/0000880641-26-000023.md) | [5,270](/filings/0000880641-26-000023.md) | [5,584](/filings/0000880641-26-000004.md) | [4,334](/filings/0000880641-26-000004.md) | [3,740](/filings/0000880641-26-000023.md) | [4,981](/filings/0000880641-26-000023.md) |
| Diluted EPS | $ per share | [0.66](/filings/0000950170-25-047778.md) | [0.69](/filings/0000950170-25-047778.md) | [0.72](/filings/0000880641-26-000004.md) | [0.89](/filings/0000880641-26-000004.md) | [0.97](/filings/0000880641-26-000004.md) | [1.74](/filings/0000880641-26-000004.md) | [(1.53)](/filings/0000880641-26-000013.md) | [0.98](/filings/0000880641-26-000023.md) | [1.04](/filings/0000880641-26-000004.md) | [0.81](/filings/0000880641-26-000004.md) | [0.69](/filings/0000880641-26-000013.md) | [0.92](/filings/0000880641-26-000023.md) |
| Basic EPS | $ per share | [0.66](/filings/0000950170-25-047778.md) | [0.69](/filings/0000950170-25-047778.md) | [0.72](/filings/0000880641-26-000004.md) | [0.89](/filings/0000880641-26-000004.md) | [0.97](/filings/0000880641-26-000004.md) | [1.74](/filings/0000880641-26-000004.md) | [(1.53)](/filings/0000880641-26-000013.md) | [0.98](/filings/0000880641-26-000023.md) | [1.04](/filings/0000880641-26-000004.md) | [0.81](/filings/0000880641-26-000004.md) | [0.69](/filings/0000880641-26-000013.md) | [0.92](/filings/0000880641-26-000023.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,801](/filings/0000950170-23-063018.md) | [1,826](/filings/0000950170-25-047778.md) | [1,783](/filings/0000950170-25-008893.md) | [1,790](/filings/0000950170-25-008894.md) | [1,882](/filings/0000950170-25-008896.md) | [1,866](/filings/0000880641-26-000004.md) | [1,904](/filings/0000950170-25-071376.md) | [2,035](/filings/0000950170-25-107957.md) | [1,932](/filings/0001193125-25-279991.md) | [1,889](/filings/0000880641-26-000023.md) | [1,838](/filings/0000880641-26-000013.md) | [1,847](/filings/0000880641-26-000023.md) |
| Total liabilities | $m | [1,700](/filings/0000950170-23-063018.md) | [1,717](/filings/0000950170-25-047778.md) | [1,675](/filings/0000950170-25-008893.md) | [1,679](/filings/0000950170-25-008894.md) | [1,764](/filings/0000950170-25-008896.md) | [1,747](/filings/0000880641-26-000004.md) | [1,728](/filings/0000950170-25-071376.md) | [1,855](/filings/0000950170-25-107957.md) | [1,747](/filings/0001193125-25-279991.md) | [1,700](/filings/0000880641-26-000023.md) | [1,648](/filings/0000880641-26-000013.md) | [1,653](/filings/0000880641-26-000023.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [69.6](/filings/0000880641-26-000023.md) | [29.6](/filings/0000880641-26-000013.md) | [29.6](/filings/0000880641-26-000023.md) |
| Shareholders' equity | $m | [101](/filings/0000950170-25-008896.md) | [108](/filings/0000880641-26-000004.md) | [108](/filings/0001193125-25-279991.md) | [111](/filings/0001193125-25-279991.md) | [118](/filings/0001193125-25-279991.md) | [119](/filings/0000880641-26-000023.md) | [176](/filings/0000880641-26-000023.md) | [180](/filings/0000880641-26-000023.md) | [186](/filings/0001193125-25-279991.md) | [189](/filings/0000880641-26-000023.md) | [190](/filings/0000880641-26-000023.md) | [194](/filings/0000880641-26-000023.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [15.1 d](/filings/0000950170-25-008896.md) | [(6.0) d](/filings/0000950170-25-047778.md) | [6.8](/filings/0000950170-25-071376.md) | [(1.8) d](/filings/0000950170-25-107957.md) | [7.5 d](/filings/0001193125-25-279991.md) | [6.3 d](/filings/0000880641-26-000004.md) | [5.8](/filings/0000880641-26-000013.md) | [2.6 d](/filings/0000880641-26-000023.md) | [8.2 d](/filings/0001193125-25-279991.md) | [9.2 d](/filings/0000880641-26-000004.md) | [4.3](/filings/0000880641-26-000013.md) | [(12.5) d](/filings/0000880641-26-000023.md) |
| Capital expenditure | $m | [0.6 d](/filings/0000950170-25-008896.md) | [(0.1) d](/filings/0000950170-25-047778.md) | [0.1](/filings/0000950170-25-071376.md) | [0.4 d](/filings/0000950170-25-107957.md) | [0.2 d](/filings/0001193125-25-279991.md) | [0.3 d](/filings/0000880641-26-000004.md) | [0.5](/filings/0000880641-26-000013.md) | [0.3 d](/filings/0000880641-26-000023.md) | [0.4 d](/filings/0001193125-25-279991.md) | [0.2 d](/filings/0000880641-26-000004.md) | [0.2](/filings/0000880641-26-000013.md) | [0.3 d](/filings/0000880641-26-000023.md) |
| Dividends paid | $m | [1.1 d](/filings/0000950170-25-008896.md) | [1.1 d](/filings/0000950170-25-047778.md) | [1.1](/filings/0000950170-25-071376.md) | [1.1 d](/filings/0000950170-25-107957.md) | [1.1 d](/filings/0001193125-25-279991.md) | [1.1 d](/filings/0000880641-26-000004.md) | [1.1](/filings/0000880641-26-000013.md) | [1.7 d](/filings/0000880641-26-000023.md) | [1.7 d](/filings/0001193125-25-279991.md) | [1.7 d](/filings/0000880641-26-000004.md) | [1.7](/filings/0000880641-26-000013.md) | [1.7 d](/filings/0000880641-26-000023.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,488](/filings/0000950170-23-063018.md) | [3,522](/filings/0000950170-25-008893.md) | [3,527](/filings/0000950170-25-008894.md) | [3,527](/filings/0000950170-25-008896.md) | [3,557](/filings/0000950170-25-071376.md) | [3,557](/filings/0000950170-25-107957.md) | [3,552](/filings/0001193125-25-279991.md) | [4,572](/filings/0000880641-26-000013.md) | [5,378](/filings/0000880641-26-000023.md) | [5,376](/filings/0001193125-25-279991.md) | [5,412](/filings/0000880641-26-000013.md) | [5,412](/filings/0000880641-26-000023.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,411,615 at 2026-08-04, from the cover of the [10-Q filed 2026-08-10](/filings/0000880641-26-000023.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.